All the patients in the phase 2 study received cyclophosphamide, tacrolimus and mycophenolate mofetil for graft-vs-host ...

Zemcelpro provides an option for people with a hematologic malignancy who need a blood stem cell transplant but have no ...

Two allogeneic stem cell transplants, including a complex and highly challenging haploidentical (half-match) transplant were performed successfully at KIMS-Health Cancer Centre, marking a significant ...

Panelists explain that KMT2A-rearranged acute myeloid leukemia (AML) is a biologically aggressive and diagnostically complex leukemia subtype—especially prevalent in pediatric and therapy-related ...

HGTV head of content Loren Ruch, who was also the co-host of HGTV’s House Party, died last Thursday (June 12). He was 55 ...

Australian researchers have demonstrated that the use of a new, less toxic drug combination after stem cell transplants for ...

Debiopharm ( a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow’s standards of care to ...

VANFLYTA (quizartinib) has been approved by Health Canada for use in combination with standard cytarabine and anthracycline ...

This single-arm, multicenter Phase II study assessed the efficacy and safety of olverembatinib in combination with the VP (vindesine+prednisone) regimen (OVP) in the first-line treatment of adult ...

Adding the menin inhibitor revumenib (Revuforj) to azacitidine and venetoclax (Venclexta) seemed to benefit older adults with ...

Revumenib shows promise for high-risk patients with acute myeloid leukemia (AML) with specific genetic mutations, ...